Macphylline 50mg/5ml Syrup contains Acebrophylline, a bronchodilator and mucolytic agent indicated for the management of respiratory conditions characterized by bronchospasm and excessive mucus secretion, such as chronic obstructive pulmonary disease (COPD), bronchitis, and asthma. Each 5ml of syrup delivers 50mg of Acebrophylline, which acts by relaxing bronchial smooth muscles, thereby improving airflow and facilitating easier breathing. Additionally, Acebrophylline exhibits mucoregulatory properties that help reduce mucus viscosity, enhancing expectoration and clearing of the airways. Macphylline is typically prescribed as an adjunctive therapy to relieve symptoms like wheezing, cough, and breathlessness associated with obstructive airway diseases. The syrup formulation allows for ease of administration, particularly in pediatric and geriatric populations. Dosage should be individualized based on the patient’s clinical condition and response to therapy, with careful adherence to prescribed guidelines to minimize potential side effects such as gastrointestinal discomfort or hypersensitivity reactions. Macphylline should be used cautiously in patients with a history of cardiac arrhythmias or hypersensitivity to xanthine derivatives. It is contraindicated in patients with known hypersensitivity to Acebrophylline or any component of the formulation. Regular monitoring and consultation with a healthcare provider are advised to ensure optimal therapeutic outcomes.